KCIA
NMTC icon

Kingsbury Capital Investment Advisors’s NeuroOne Medical Technologies NMTC Stock Holding History

Kingsbury Capital Investment Advisors’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,901
Closed -$44K – 88
2022
Q2 		$44K Buy
+8,901
New +$49.5K 0.06% 88

Other funds holding NMTC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DWM
Drive Wealth Management Lehi, Utah $561M AUM 33.14% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NCG
Newport Capital Group Red Bank, New Jersey $178M AUM 12.73% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Kingsbury Capital Investment Advisors's NMTC Position: Q3 2022 in Review

Kingsbury Capital Investment Advisors sold out of NeuroOne Medical Technologies (NMTC) in Q3 2022, closing a stake of 8,901 shares — an estimated $44K sold.

Kingsbury Capital Investment Advisors first reported a position in NMTC in Q2 2022 and held it in 1 quarter. The position peaked at $44K in Q2 2022. 11 funds tracked by Wall St. Rank hold NMTC as of Q3 2022.

  • Kingsbury Capital Investment Advisors reported no remaining NeuroOne Medical Technologies position as of Q3 2022 after selling out during the quarter.
  • Kingsbury Capital Investment Advisors sold 8,901 NeuroOne Medical Technologies shares in Q3 2022, an estimated $44K.
  • Kingsbury Capital Investment Advisors first reported a position in NeuroOne Medical Technologies in Q2 2022 and held it in 1 quarter.
  • Kingsbury Capital Investment Advisors's NeuroOne Medical Technologies position peaked at $44K in Q2 2022.
  • 11 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2022.

Based on Kingsbury Capital Investment Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.